Omega Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Omega Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Omega Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $109M, a 0.77% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $109M -$849K -0.77% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $107M +$9.12M +9.3% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $107M +$105M +3830% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $109M +$105M +2864% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $110M +$105M +2294% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $98.1M +$92.5M +1675% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.73M -$3.71M -57.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.67M Dec 31, 2022 10-K 2024-03-28
Q3 2022 $4.6M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $5.53M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.44M Mar 31, 2022 10-Q 2022-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.